Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Eli Lilly invests $1B in India as US drugs flood market
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 64373, member: 636"] Eli Lilly will invest over $1 billion in India over the coming years to expand its contract manufacturing capabilities, the U.S. pharmaceutical company announced on Monday. The investment aims to improve global access to treatments for obesity, diabetes, Alzheimer's disease, cancer, and autoimmune disorders. The company will establish a manufacturing and quality facility in Hyderabad to provide technical oversight for its contract manufacturing operations throughout India. Lilly will begin hiring engineers, chemists, analytical scientists, quality professionals, and managers to support the expansion. Nivruti Rai, managing director of Invest India under the Ministry of Commerce and Industry, said the investment demonstrates confidence in India's workforce, infrastructure, and policies. Telangana Chief Minister A. Revanth Reddy noted the project reinforces his state's status as a destination for healthcare investments following Lilly's recent innovation site opening in the region. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Eli Lilly invests $1B in India as US drugs flood market
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top